Variant report
Variant | nsv519494 |
---|---|
Chromosome Location | chr6:69619007-69638504 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs386702397 | chr6:69619007-69619008 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs6938903 | chr6:69619010-69619011 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs527311363 | chr6:69619035-69619036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs556000550 | chr6:69619036-69619037 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs530484997 | chr6:69619042-69619043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs12197269 | chr6:69619043-69619044 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs564345891 | chr6:69619047-69619048 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs533179313 | chr6:69619053-69619054 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs114102430 | chr6:69619086-69619087 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs79798924 | chr6:69619089-69619090 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs528627374 | chr6:69619106-69619107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs548657373 | chr6:69619149-69619150 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs568362462 | chr6:69619150-69619151 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs151251635 | chr6:69619182-69619183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs182841834 | chr6:69619192-69619193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs570842227 | chr6:69619235-69619236 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs539722049 | chr6:69619276-69619277 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs553336500 | chr6:69619301-69619302 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs188142438 | chr6:69619363-69619364 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs541569223 | chr6:69619368-69619369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs192918178 | chr6:69619412-69619413 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs549950747 | chr6:69619424-69619425 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs369166672 | chr6:69619453-69619454 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs9454645 | chr6:69619463-69619464 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs117918349 | chr6:69619517-69619518 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs546519345 | chr6:69619520-69619521 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs533297535 | chr6:69619548-69619549 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs564502984 | chr6:69619564-69619565 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs140482507 | chr6:69619565-69619566 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs182431939 | chr6:69619587-69619588 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs150422926 | chr6:69619590-69619591 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs572346419 | chr6:69619597-69619598 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs568515219 | chr6:69619623-69619624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs576492392 | chr6:69619654-69619655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs530893004 | chr6:69619688-69619689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs550597628 | chr6:69619739-69619740 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs570504737 | chr6:69619758-69619759 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs58011260 | chr6:69619761-69619762 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs543768275 | chr6:69619762-69619763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs187427991 | chr6:69619791-69619792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs562042784 | chr6:69619833-69619834 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs377354823 | chr6:69619844-69619845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs566961524 | chr6:69619884-69619885 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs9454646 | chr6:69619916-69619917 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs555190892 | chr6:69619987-69619988 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs575437663 | chr6:69620007-69620008 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs13216650 | chr6:69620033-69620034 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs557824615 | chr6:69620054-69620055 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs577707208 | chr6:69620061-69620062 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs192024167 | chr6:69620102-69620103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 20164919 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 22522925 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:69602800-69621000 | Weak transcription | Fetal Lung | lung |
2 | chr6:69621200-69622000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr6:69621400-69621800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
4 | chr6:69632000-69632800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
5 | chr6:69632200-69632600 | Enhancers | H9 Cell Line | embryonic stem cell |
6 | chr6:69632200-69632800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
7 | chr6:69632200-69632800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr6:69632200-69633000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
9 | chr6:69632400-69632800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
10 | chr6:69632400-69633000 | Enhancers | HUES48 Cell Line | embryonic stem cell |